Investor Relations

Covalon Annual & Special Meeting of Shareholders

Please note the following change:

The Record Date for the meeting will be April 19, 2010.

Covalon was recognized as a TSX Venture 50™ company in both 2008 and 2007

The TSX Venture 50 are the top 10 companies in each of five major industry sectors - mining, oil & gas, technology & life sciences, diversified industries and cleantech - based on a ranking formula with equal weighting given to one year revenue (last reported 12 months), return on investment, market cap growth and trading volume. All data was as of December 31, 2007, and December 31, 2006, respectively.

TSX Venture 50 is a trade-mark of TSX Inc. and is used under license.

Medical Devices' Silver Bullet

  
Antimicrobial devices for preventing infections are becoming indispensable components of implantable medical devices. Read the whole story at www.devicelink.com/mpmn/archive/09/07/012.html

Investor Presentation, March 6, 2009

Press Releases

Financial Results 2009-2010

Financial Results 2008-2009

Financial Results 2007-2008

Financial Results 2006-2007

Trading under the symbol COV

Publicly filed documents can also be found via the System for Electronic Document Analysis and Retrieval.

    
Some documents on this website are in PDF format and require Adobe Acrobat Reader.
Should you need to install this software, click on the Adobe icon. 

Additional Information

To receive personalized and specific information, please do not hesitate to contact us.

Covalon Technologies Ltd.
405 Britannia Road East, Suite 106
Mississauga, Ontario   L4Z 3E6
tel 905.568.8400
fax 905.568.5200
office@covalon.com